Small cap round up
AIM-listed explorer Bacanora Minerals said it had gained the necessary funds during to progress with a feasibility study at its lithium carbonate project in Mexico. For the year ended 30 June, the company had £29m in cash raised partly from two equity placings.
Advanced ultrasound skills training simulator provider MedaPhor Group announced on Thursday that the University of Derby has purchased an additional six ScanTrainer ultrasound simulators for its new Ultrasound Simulation Suite, which it said will act as a learning centre for students on the University's ultrasound master's degree courses.
African gold producer Goldplat posted an operations update for the three months to 30 September on Thursday, with overall production of 9,129 ounces of gold and gold equivalents achieved during the quarter.The AIM-traded company said that occurred alongside improvements in operating profitability at the recovery operations and the continued reduction in losses made at Kilimapesa.
Mobile workforce management software provider ServicePower Technologies announced on Thursday that it has signed a new three-year contract with BrandsMart USA for its ServiceScheduling, ServiceOperations and ServiceGPS products.The AIM-traded firm said BrandsMart USA, a North American retailer headquartered in Florida, uses ServiceScheduling to optimise scheduling and routing of its ‘in home’ and ‘bench’ repair teams;who provide services under both manufacturer and extended warranty coverage.
AIM-listed advanced materials company Versarien’s subsidiary 2-DTech, which specialises in graphene production, is to participate in a £5.2m project to explore how graphene can improve major health problems, its first project in the biomedical area.The five-year project, which is funded by the Engineering and Physical Sciences Research Council, is to find out how graphene can help overcome health challenges such as cancer, diabetes and dementia.
Innovative technology business investor Mercia Technologies announced a follow-on investment of £1m into Oxford Genetics, a synthetic biology company with significant expertise in DNA design, on Thursday.The AIM-traded firm said the investment follows the recent expansion of Oxford Genetics' board and its relocation to new, state-of-the-art facilities at Oxford Science Park.